Lv11
60 积分 2023-11-04 加入
Assessing validity of existing fistula-in-ano classifications in a cohort of 848 operated and MRI-assessed anal fistula patients – Cohort study
27分钟前
待确认
Comparison of Ustekinumab and Vedolizumab Effectiveness in Perianal Crohn's Disease: A Retrospective Propensity Matched Cohort Study
1个月前
已完结
Dual biologic therapy with Vedolizumab and Ustekinumab for refractory Crohn's disease in children
1个月前
已完结
Combination biologic therapy in pediatric inflammatory bowel disease: Safety and efficacy over a minimum 12-month follow-up period
1个月前
已完结
A practical guide to combination advanced therapy in inflammatory bowel disease
1个月前
已完结
Progressing advanced therapies for inflammatory bowel disease: Current status including dual biologic therapy and discontinuation of biologics
1个月前
已完结
Research Communication: Combination Therapy of Upadacitinib With Infliximab, Risankizumab, Ustekinumab or Vedolizumab for Refractory Crohn's Disease: A Descriptive Case Series
1个月前
已完结
A Deep Learning Model for Breast Shear Wave Elastography to Improve Breast Cancer Diagnosis (INSPiRED 006): An International, Multicenter Analysis
1个月前
已完结
The real-world analysis of adverse events with teduglutide: a pharmacovigilance study based on the FAERS database
2个月前
已完结
Durable clinical and deep remission with ustekinumab in perianal fistulizing Crohn's disease: A 2-year retrospective real-world cohort study
3个月前
已完结
皖公网安备34019202002308
